Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes.
Journal:
Transfusion
61(10):2830-2836
Publish Date:
2021-10-01
Author Profiles:
DBS and Autonomy: Clarifying the Role of Theoretical Neuroethics.
Evidence generation and reproducibility in cell and gene therapy research: A call to action.
Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study.
Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease.
TNPO2 variants associate with human developmental delays, neurologic deficits, and dysmorphic features and alter TNPO2 activity in Drosophila.
Journal:
Am J Hum Genet
108(9):1669-1691
Publish Date:
2021-09-02
Author Profiles:
How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices?
Journal:
AMA J Ethics
23(9):E673-678
Publish Date:
2021-09-01
Author Profiles:
Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe.
Journal:
JAMA Oncol
7(9):e212026
Publish Date:
2021-09-01
Author Profiles:
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer.
International reference pricing for prescription drugs: a landscape analysis.
Journal:
J Manag Care Spec Pharm
27(9):1309-1313
Publish Date:
2021-09-01
Author Profiles: